Novo Nordisk insulin finally approved in the US

Danish pharmaceutical giant has high hopes for products

The Danish pharmaceutical giant Novo Nordisk has announced that the US health authority, the FDA, has approved two of its products for the treatment of diabetes on the American market.

It has taken two years for the FDA to approve the two products, Tresiba and Ryzodeg, which help treat adults suffering from Type-1 and Type-2 diabetes.

“Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes, and we are proud to bring forward the first new basal insulin molecule to be approved by the FDA in 10 years,” said Jesper Høiland, the president of Novo Nordisk in the US.

“Novo Nordisk is excited to launch Tresiba in the United States in the first quarter of 2016.”

READ MORE: Novo Nordisk to invest billions into US factory

Huge health issue
Novo Nordisk originally applied for approval on the US market in 2013, but the FDA was not convinced by the product, so the company undertook a clinical study regarding the risk of using the product.

The company has massive expectations for the US market and expects the products, already approved in Europe and Japan, to be among the leading diabetic products there within a few short years.

Over 29 million people are affected by diabetes in the US. Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases. The number of Americans with diabetes has tripled over the past 30 years.

TOP STORIES

  • Danish Intelligence Service: Threat from Russia has intensified

    Danish Intelligence Service: Threat from Russia has intensified

    In the internal Danish waters, Russia will be able to attack underwater infrastructure from all types of vessels. The target could be cables with data, electricity and gas, assesses the Danish Defense Intelligence Service

  • Denmark to explore screening citizenship applicants for anti-democratic sentiments

    Denmark to explore screening citizenship applicants for anti-democratic sentiments

    A few weeks after Alex Vanopslagh’s comments about “right values,” the government announced that an expert committee would be established to examine the feasibility of screening citizenship applicants for anti-democratic attitudes.

  • The Future Copenhagen

    The Future Copenhagen

    The municipality plan encompasses building 40,000 houses by 2036 in order to help drive real estate prices down. But this is not the only huge project that will change the shape of the city: Lynetteholmen, M5 metro line, the Eastern Ring Road, and Jernbanebyen will transform Copenhagen into something different from what we know today

  • It’s not you: winter depression is affecting many people

    It’s not you: winter depression is affecting many people

    Many people in Denmark are facing hard times marked by sadness, anxiety, and apathy. It’s called winter depression, and it’s a widespread phenomenon during the cold months in Nordic countries.

  • Crime rates are rising, but people are safer

    Crime rates are rising, but people are safer

    Crime in Denmark is increasing for the second consecutive year, but it is more focused on property, while people appear to be safer than before. Over the past year, there were fewer incidents of violence

  • Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

Want to advertise your job with CPH Post?

Contact us

Jobs